| Product Code: ETC6739198 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 & 2031F |
3.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Industry Life Cycle |
3.4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Porter's Five Forces |
3.5 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Analytical Method, 2021 & 2031F |
3.7 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.8 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in cell and gene therapy research and development in China |
4.2.2 Favorable government regulations and policies supporting the growth of the cell and gene therapy sector |
4.2.3 Rising demand for high-quality manufacturing processes and quality control in the cell and gene therapy industry |
4.3 Market Restraints |
4.3.1 Lack of standardized quality control protocols and guidelines in the cell and gene therapy manufacturing sector in China |
4.3.2 Limited expertise and skilled workforce for implementing advanced quality control measures in manufacturing processes |
5 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trends |
6 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Types |
6.1 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Equipment & Accessories, 2021- 2031F |
6.1.4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method |
6.2.1 Overview and Analysis |
6.2.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Sterility Testing, 2021- 2031F |
6.2.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Purity Testing, 2021- 2031F |
6.2.4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Potency Testing, 2021- 2031F |
6.2.5 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Identity Testing, 2021- 2031F |
6.2.6 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Process |
6.3.1 Overview and Analysis |
6.3.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Upstream Processes, 2021- 2031F |
6.3.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Downstream Processes, 2021- 2031F |
6.3.4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Process Development, 2021- 2031F |
6.4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
7 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Import-Export Trade Statistics |
7.1 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Export to Major Countries |
7.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Imports from Major Countries |
8 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Key Performance Indicators |
8.1 Percentage increase in adoption of advanced quality control technologies in cell and gene therapy manufacturing processes in China |
8.2 Number of collaborations between academic institutions, research organizations, and industry players to improve quality control standards in the sector |
8.3 Improvement in compliance rates with regulatory quality control standards in cell and gene therapy manufacturing facilities in China |
8.4 Reduction in product recalls and quality control-related issues in the cell and gene therapy industry. |
9 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Opportunity Assessment |
9.1 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Analytical Method, 2021 & 2031F |
9.3 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Process, 2021 & 2031F |
9.4 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Competitive Landscape |
10.1 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenue Share, By Companies, 2024 |
10.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here